Filing Details

Accession Number:
0001567619-21-022227
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-17 13:38:57
Reporting Period:
2021-12-16
Accepted Time:
2021-12-17 13:38:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882361 Aptose Biosciences Inc. APTO Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761487 G. William Rice C/O Aptose Biosciences Inc.
251 Consumers Road, Suite 1105
Toronto A6 M2J 4R3
Chair, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2021-12-16 13,183 $1.52 343,252 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.50 to $1.152, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.